Expanding access to new agents for children with refractory cancers: the experimental therapeutics program at Children's Hospital of Colorado.
|
Children’s Hospital Colorado / Lia Gore, MD |
Phase I/II Infrastructure Grants |
2009 |
Colorado |
Exploring a novel immunotherapy: cooperation of endogenous CD8+ t-cells and exogenous, allogeneic CD4+ t-cells.
|
The Johns Hopkins University School of Medicine / Heather Symons |
Young Investigator Grants |
2009 |
Maryland |
Genetic Analysis of Pediatric Gliomas |
Baylor College of Medicine / Will Parsons, MD, PhD |
'A' Award Grants |
2009 |
Texas |
Genetic Regulators of ER Stress-induced Apoptosis in Pediatric Malignancies
|
Dana-Farber Cancer Institute / Ujwal Pyati |
Young Investigator Grants |
2009 |
Massachusetts |
GSTM4, a novel target for treating Ewing sarcoma.
|
Huntsman Cancer Institute / Wen Luo |
Young Investigator Grants |
2009 |
Utah |
Identification of FDA approved drugs with anti-tumor activity in rhabdomyosarcoma.
|
Massachusetts General Hospital / David Langenau |
Young Investigator Grants |
2009 |
Massachusetts |
Identification of proteins interacting with ALK in neuroblastoma.
|
Dana-Farber Cancer Institute / Rani George |
Young Investigator Grants |
2009 |
Massachusetts |
Identifying novel biomarkers for risk stratification in t-cell acute lymphoblastic leukemia (ALL).
|
University of California San Francisco / Michelle Hermiston, MD, PhD |
Young Investigator Grants |
2009 |
California |
Identifying Rare Genetic Variants Involved in High Risk Pediatric Leukemia Via Pooled Sequencing |
Washington University / Todd Druley, MD, PhD |
'A' Award Grants |
2009 |
Missouri |
Immune Stimulatory Antigen Loaded Particles (ISAPS) for the Treatment of Solid Childhood Tumors
|
Children’s National Medical Center / Suzanne Miles |
Young Investigator Grants |
2009 |
District of Columbia |